Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

We aimed to analyze the value of seizure reduction and radiological response as prognostic markers of survival in patients with low-grade glioma (LGG) treated with temozolomide (TMZ) chemotherapy. We retrospectively reviewed adult patients with a progressive LGG and uncontrolled epilepsy in two hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Koekkoek, Johan A. F., Dirven, Linda, Heimans, Jan J., Postma, Tjeerd J., Vos, Maaike J., Reijneveld, Jaap C., Taphoorn, Martin J. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718947/
https://www.ncbi.nlm.nih.gov/pubmed/26547911
http://dx.doi.org/10.1007/s11060-015-1975-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718947/
https://www.ncbi.nlm.nih.gov/pubmed/26547911
http://dx.doi.org/10.1007/s11060-015-1975-y

Ejemplares similares